BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230517T093000
DTEND;TZID=Europe/London:20230517T133000
DTSTAMP:20260408T154021
CREATED:20230309T135351Z
LAST-MODIFIED:20230630T075331Z
UID:22595-1684315800-1684330200@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: NBIC Showcase: Supporting Collaboration for Impact in Biofilm Research
DESCRIPTION:  \n  \nDelegates at this event will hear about the extensive opportunities offered by the National Biofilm Innovation Centre (NBIC) and Medilink Midlands to support collaboration between academia and industry in the area of biofilm research and innovation. Presentations and tours will provide an opportunity to see the state-of-the-art facilities available to characterize biofilms at the University of Nottingham or through NBIC partners. \nA selection of projects that exemplify successful collaborations between academia and industry will be presented by experts in the field\, and there will be the opportunity for delegates to pitch ideas for new collaborations. Networking will be facilitated over coffee and lunch breaks\, during the tours and by interacting with allied support organisations who will be present. \nInnovation vouchers are available\, please click here to access the guidance: Innovation voucher guidance\nAgenda\n09.30 Arrival/registration/coffee \n10.00 Welcome and introductions: Kim Hardie (Biodiscovery Institute\, School of Life Sciences\, University of Nottingham & NBIC) and Caroline Sykes (Medilink Midlands) \n10.05 Miguel Cámara (Biodiscovery Institute\, School of Life Sciences\, University of Nottingham & NBIC): ‘Introduction to NBIC: Nottingham research and infrastructure‘ \n10.25 Platform facilities at the University of Nottingham \n\nTim Self/Robert Markus: ‘School of Life Sciences Imaging (SLIM): a world class facility’\nDr Matthew Piggott: ‘Nanoscale & Microscale Research Centre (nmRC): Correlative Imaging and Compositional Analysis’\n\n10.40 Pitch 1: Paul S Browning\, Freedom Hygiene Ltd \n10.45 Pitch 2: Jinju Chen (Vicky)\, Newcastle University \n10.50 Paul Williams (Biodiscovery Institute\, School of Life Sciences\, University of Nottingham): ‘Anti biofilm coatings on catheters’ TBC \n11.10 Coffee Break \n11.40 Alvaro Mata (School of Engineering\, University of Nottingham): ‘Biocooperative approaches to engineer biofilm models’ \n12.00 Sarah Kuehne (School of Dentistry\, University of Birmingham): ‘Oral biofilm models’ TBC \n12.20 Pitch 3: Jeni Luckett\, University of Nottingham \n12.25 Pitch 4: TBC \n12.30 Caroline Sykes (Medilink Midlands): ‘Nottingham City Shared Prosperity Fund opportunities.’ \n12.45 Summary and presentations conclude: Kim Hardie and Miguel Cámara \n13.00 Networking lunch \n13.30 Tours: \n\nBDI pathogen imaging/robots/compound library (Robert Markus)\nnmRC (Matt Piggott)\n\n15.30 Depart \nIn addition to the formal presentations\, we are also offering an optional tour\, which is anticipated to finish at 3pm. \nDirections and Arrival Information: For directions to the University Park campus as well as a detailed campus map\, please click here. The event is taking place in at the Boots Science Building\, which is building number 44 on the campus map. \nOn arrival to the Boots Science Building\, you will find the Medilink Midlands registration desk in the main foyer\, where you will need to sign and collect your name badge. \nArriving by Car: We have a limited number of event parking spaces available to our attendees (not applicable to University of Nottingham attendees). If you require a car parking space\, please let me know as soon as possible as these will be offered on a first-come\, first-served basis\, for which you will require a parking voucher. Alternatively\, delegates can park in the main Visitors Car Park which is located at the bottom of E2 on the campus map. Please note that there is a short walk from the main car park to the venue and that parking is pay and display. The parking fee can be paid either at the machine or via the RingGo app at a cost of £7 for 4 hours or £10 for the full day. \nArrival by Tram: We recommend the tram as a convenient mode of transport for this event. The University of Nottingham stop on the Toton Lane line arrives directly opposite the Boots Science Building (you just need to exit the bridge via the stairs). Further information is available via the NetGo app\, where you can also buy e-tickets for your journey. \nTour of the NBIC facilities:In addition to the formal presentations\, we are also offering an optional tour\, which is anticipated to finish at 3pm. \nThis free-to-attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to companies in the D2N2/NG area and is open to all.
URL:https://staging.medilinkmidlands.com/event/nbic-showcase/
LOCATION:University of Nottingham School of Pharmacy
CATEGORIES:Medilink Midlands Event,Project Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230510T093000
DTEND;TZID=Europe/London:20230510T133000
DTSTAMP:20260408T154021
CREATED:20230209T135310Z
LAST-MODIFIED:20230502T134952Z
UID:22185-1683711000-1683725400@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: The Fight Against Antibiotic Resistance: From Bench to Bedside
DESCRIPTION:The first Infectious Diseases Special Interest Group of 2023 brings together academic\, clinician and industry experts to explore the latest developments in the field of antibiotic resistance. We’re pleased to be able to hold this event in person at MeetPoint Midlands\, allowing ample opportunity for networking and discussion beyond our exciting panel of formal presentations. \nOur Chair\, Professor Katie Laird\, Professor of Microbiology at De Montfort University (DMU)\, will be joined on the day by: \n\nDr Rahmi Yusuf\, Lecturer in Pharmaceutical Microbiology\, DMU\nDr Grace Edmund\, Senior Computational Chemist\, Oxford Drug Design\nStephanie Lesage\, Co-Founder and CEO\, Oxford Silk Phage Technologies Ltd\n\nMoreover\, delegates are invited to deliver a 5-minute pitch relating to the broader SIG area. Use this time as you wish – to invite knowledge exchange on a particular area of the subject\, showcase a new development that you’re currently working on\, and to highlight collaborative opportunities to other innovators and facilitators in attendance. \nInterested in delivering a 5-minute pitch? Please email info@medilinkmidlands.com with your name\, company\, and an overview of what you wish to share within your timeslot. \nThis free-to-attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. \nPlease note: whilst this event is held as part of the SoLSTICE programme\, attendance is not restricted to companies in the Leicester/Leicestershire area and is open to all. \nCLICK HERE TO BOOK YOUR PLACE\nSpeaker Profiles \n \nDr Rahmi Yusuf\, Lecturer in Pharmaceutical Microbiology\, DMU \nPresentation topic: Designing a Biological Platform for High-Throughput Screening of Novel Antibacterial Compounds \nRahmi’s journey as a microbiologist began in her home country\, Indonesia\, after completing a Bachelor in Microbiology in 2008\, specialising in Industrial Microbiology. Following a number of short industry internships back home\, she enrolled in a graduate programme in Biomedical Engineering at Hochschule Furtwangen University\, Germany\, which she completed in 2012. Supported by a full government scholarship\, Rahmi then completed her doctoral studies at the University of Portsmouth in 2019\, researching the fundamental study of bacterial two-component systems and harnessing their potential as synthetic biosensors. Rahmi carried on this research for a further 2.5 years as a Senior Research Associate\, before joining the School of Pharmacy at DMU as Lecturer in Pharmaceutical Microbiology. \n \nDr Grace Edmund\, Senior Computational Chemist\, Oxford Drug Design \nPresentation title: Targeting Antibiotic Resistance through a Novel Class of Gram-Negative Antibacterial Agents \nDr Grace Edmund is a Senior Computational Chemist at Oxford Drug Design where she leads the computational chemistry effort for their tRNA synthetase antibacterial drug discovery project. Prior to joining Oxford Drug Design in 2015\, she completed post-doctoral research at the University of Surrey in collaboration with DSTL. She received her MChem in Chemistry from Durham University and PhD in Computational Chemistry from the University of Surrey. \n \nDr Stephanie Lesage\, Co-Founder & CEO\, Oxford Silk Phage Technologies Ltd \nPresentation title: Deploying Bacteriophages to Preserve Antibiotics \nStephanie Lesage has a multidisciplinary background in biological sciences (BSc)\, technical textile engineering (MEng) and medical devices (MSc)\, with 19 years of start-up leadership experience. She is CEO of Oxford Silk Phage Technologies Ltd\, a company she co-founded in 2020\, developing a novel antibacterial material integrating bacteriophages to produce medical implants which will reduce surgical site infections and antibiotic use. Stephanie is also a founding member of Phage-UK (2021)\, aiming to make phage therapy more widely available to UK patients and she was recently invited to the House of Commons to provide oral evidence on the potential for bacteriophage therapy in the UK.
URL:https://staging.medilinkmidlands.com/event/antibiotic-resistance/
LOCATION:MeetPoint Midlands\, Conference Centre\, 28 High Street\, Kegworth\, Derbyshire\, DE74 2DA
CATEGORIES:Medilink Midlands Event,Project Event
ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230509T130000
DTEND;TZID=Europe/London:20230509T140000
DTSTAMP:20260408T154021
CREATED:20230329T130944Z
LAST-MODIFIED:20230505T091210Z
UID:22889-1683637200-1683640800@staging.medilinkmidlands.com
SUMMARY:EMAHSN Innovation Academy – Live Q&A – Module C: Attracting Private Investment
DESCRIPTION:The East Midlands Academic Health Science Network Innovation Academy is open to all. Once registered\, participants will have access to a series of 10 modules\, each including an on-demand webinar\, accompanying scheduled live Q&A session\, as well as a range of online resources. \nFor further details/to watch the ON-DEMAND webinar or join the live Q&A session please CLICK HERE to sign up for the Academy and to register for this module.\nLed by Gemma Sturt\, Investment Manager at Pioneer group\, this module supports innovators looking for private investment. Gemma provides an overview of the different types of investments and investors\, alongside timelines and mechanisms for obtaining funding. \nGemma discusses various routes including non-dilutive grants and awards\, emphasising the different types of funding that are potentially available. The session also covers venture capital\, outlining both the venture capital and associated due diligence process. \nIn this module\, you’ll learn how to approach investors strategically\, to give you the optimal chance of success. Finally\, the module highlights why research is so important when seeking to secure investment and advises on how to keep a targeted approach to attracting investment throughout your innovation journey. \nPresenter \n\n  \n  \n  \n  \nGemma Sturt\, Investment Manager\, Pioneer Group
URL:https://staging.medilinkmidlands.com/event/emahsn-innovation-academy-live-qa-module-c-attracting-private-investment/
CATEGORIES:Medilink Midlands Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230503T093000
DTEND;TZID=Europe/London:20230503T133000
DTSTAMP:20260408T154021
CREATED:20230330T115004Z
LAST-MODIFIED:20230428T184725Z
UID:22974-1683106200-1683120600@staging.medilinkmidlands.com
SUMMARY:Insights for Industry: Routes to Market and NHS Adoption
DESCRIPTION:       \nThe aim of this industry-focused event\, hosted by Medilink Midlands and Nottingham Trent University (NTU)\, is to offer information and insights into routes to market and NHS adoption for new innovations. NHS Supply Chain work with partners such as NHS England\, NHS Improvement\, the National Institute for Health\, Care Excellence (NICE)\, and The AHSN Network to support the introduction of new technology and innovation into the NHS that provides demonstrable benefits for patients and users. \nThe event will be led by Marc Naughton and Fay Allen from the NHS Supply Chain team\, giving an overview of how procurement works in the NHS; the structure of hospital procurement and how it works in practice; key processes / stages / supports within the NHS Supply Chain\, as well as information on drivers for change and routes to market for novel innovation development. \nThe event is open to industry partners from across the region and will include tours of the facilities at NTU’s Clifton Campus including the Medical Technology Innovation Facility and the Institute for Heath and Allied Professions. \nCLICK HERE TO BOOK YOUR PLACE TODAY\nProgramme \n\n09:30 – Delegate registration and welcome refreshments\n10:00 – Welcome and Introductions\n10:05 – Marc Naughton\n10:25 – Fay Allen and Michaela Russell\n10:45 – Discussion & Q&A\n11:00 – BREAK – Networking and refreshments\n11:30 – Sachin Gohil\n11:50 – Q&A and Panel discussion\n12:00 – Lunch & Networking\n13:00-14:00 – Optional tour of MTIF/IHAP (approx. 1 hours and ends at Visitor Car Park)\n\nSpeaker Profiles \n \nMarc Naughton\, Clinical Engagement and Implementation Manager & Senior Pandemic\, NHS Supply Chain \nMarc has 23 years’ experience working for the NHS\, initially at the North West Ambulance Service as a Senior Paramedic and Manager. In 2015 he joined the Department of Health with the Clinical Evaluation Team to prove the concept that involving clinicians nationally within procurement could improve the quality\, safety and value of products used in the NHS. The success and alignment to Lord Carter Report into “unwarranted variation” helped to establish clinicians at the centre of NHS Supply Chain. After working to establish the Clinical and Product Assurance Team he joined Collaborative Procurement Partnership CPP in 2018 to help embed the clinical voice into procurement activity. Marc is currently focused on the following product areas. Orthoses and Podiatry\, Physiotherapy and Occupational Therapy\, Immobilisation and Prosthetics. \n \nFay Allen\, Innovation Specialist\, NHS Supply Chain \nFay has been a registered nurse for 24 years\, and has worked across the United Kingdom and Ireland\, in a variety of Roles and clinical specialties.  Fay Moved to NHS Supply chain 4 years ago as part of the Clinical and Product Assurance Directorate\, as a Product Assurance specialist\, her work in this area focused on Novel and new innovation products\,  co – developing the Innovation pathway with in NHS supply chain Focusing on eth Clinical need and the value for patients and Clinicians and her current position as Innovation Specialist. \nMichaela Russell\, Innovation Specialist\, NHS Supply Chain \nMichaela has worked in Procurement for 17 years\, across national and regional projects from Pharmaceuticals\, clinical and non-clinical procurement.  Areas of employment \, Resource procurement hub\, East Midlands pharmacy collaborative\, within local trust Nottingham University Hospitals before moving to NHS Supply chain 5 years ago as a category Tower Manager\, during this time she worked closely with NHSE on the Med Tech Funding Mandate policy and implemented this within NHS Supply chain\, this lead on to her co developing  the Innovation pathway  focusing on legal compliant routes for Innovations and her current position as Innovation Specialist. \n \nSachin Gohil\, Chief Commercial Officer\, Apos Health \nSachin is responsible for market adoption of Apos across the NHS. He has over 20 years of experience in healthcare\, having held clinical specialist and senior leadership roles at one of the largest acute Trusts in the UK. Previously\, Sachin was the Principal Pharmacist leading medicine optimisation programs at Optum UK. He is a passionate advocate for change and has led complex change processes within multi-provider organisations and systems\, acquiring a deep understanding of patient needs\, staff well-being\, and community development.
URL:https://staging.medilinkmidlands.com/event/ntu-nhs-supplychain/
LOCATION:Medical Technologies Innovation Facility (MTIF)\, Clifton Campus\, NTU\, Clifton Lane\, Nottingham\, Nottinghamshire\, NG11 8NS
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230427T100000
DTEND;TZID=Europe/London:20230427T110000
DTSTAMP:20260408T154021
CREATED:20230330T184928Z
LAST-MODIFIED:20230330T184928Z
UID:22984-1682589600-1682593200@staging.medilinkmidlands.com
SUMMARY:EMAHSN Innovation Academy - Live Q&A - Module B: Pricing Mechanisms: An Introduction to the National Tariff Payment System
DESCRIPTION:The East Midlands Academic Health Science Network Innovation Academy is open to anyone to register. Once registered\, participants will have access to a range of modules\, each including a webinar\, live Q&A session with the experts and online resources. The webinars are on demand\, so can be accessed at any time\, with the live Q&A session for each module being scheduled throughout 2023. \nFor further details/to watch the ON-DEMAND webinar or join the live Q&A session please CLICK HERE to Sign up for the Academy and to register for this module.\nThis module explores how the payment scheme in the NHS works. Chris delves deeper throughout his presentation on this and explains how money is allocated to NHS England. All of this occurs whilst Chris scopes out the structure of the national tariff in a user-friendly way. Patients are also coded within the NHS and this is broken down and explained in detail\, so one can come away from the presentation fully competent with this process. Finally\, the module highlights the way that money flows between providers and commissioners. \nPresenter / expert details\n\n\n Chris Skilbeck – Head of Engagement and Operations\, NHS England and Improvement
URL:https://staging.medilinkmidlands.com/event/emahsn-innovation-academy-live-qa-module-b-pricing-mechanisms-an-introduction-to-the-national-tariff-payment-system/
LOCATION:Online – GoToMeeting
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230419T100000
DTEND;TZID=Europe/London:20230419T110000
DTSTAMP:20260408T154021
CREATED:20230208T154023Z
LAST-MODIFIED:20230315T121835Z
UID:22155-1681898400-1681902000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Are Your Promotional Materials Compliant?
DESCRIPTION:From websites\, conference collateral\, digital/printed ads\, audio-visual material through to prescribing information; promotional copy requires a technical review in order to prevent violations of industry codes and to ensure that legal guidelines are followed. \nJensonR+ work with you to make the promotion and launch of your product a success. They provide both medical and regulatory review and certification services for promotional copy through our team of registered copy approvers. JensonR+ can review your promotional literature\, advise you on campaign strategy and key messages\, and obtain regulatory approval through pre-vetting where necessary. \nJoin us for this free-to-attend webinar\, which gives an overview of the following topics\, what copy approval is\, and why it is required: \n\nPrescription-only medicines\nOver-the-counter medicines\nFood supplements\n\n\n\n\nCosmetics\nMedical Devices\nEvents and conference compliance\nProofreading services\n\n\n\nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\nSpeaker Profiles\n \nJames Hall\, Director\, JensonR+ \nJames joined JensonR+ Ltd in 2012 and has over 25 years’ regulatory experience predominantly in the OTC sector of the industry. \nHis background covers a wide spectrum of areas including regulatory strategy and implementation\, borderline products\, promotional copy approval\, reclassifications\, medical devices and pharmacovigilance. James has worked with several major pharmaceutical companies and a wide scope of entrepreneurial clients. He is a board member within JensonR+ Ltd. \nJames has a degree in Applied Biology and is a fellow of TOPRA. \nHis role within Jenson covers business development\, regulatory strategy and implementation for clients\, promotional copy review and regulatory team management. \n \nMihai Inceu\, Senior Regulatory Officer\, JensonR+ \nMihai is currently based in London and Nottingham for JensonR+ Ltd. While at the Faculty of Chemistry in Cluj-Napoca\, Mihai was awarded a research scholarship for a study monitoring pesticide residue in Romanian wines\, while also working on developing extraction techniques to enable the identification of fake food products on the market. \nAfter a short spell at Ranbaxy as a Bioequivalence Scientist\, Mihai worked for 5 years at Nelsons within quality control\, quality assurance\, and later Regulatory Affairs\,  where he focused on food supplements\, cosmetics\, traditional herbal remedies and homeopathic remedies. He has expertise in regulatory complications relating to uncategorised products
URL:https://staging.medilinkmidlands.com/event/compliance-approval/
LOCATION:Online
CATEGORIES:Featured,Medilink Midlands Event
ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230329T093000
DTEND;TZID=Europe/London:20230329T124500
DTSTAMP:20260408T154021
CREATED:20230309T140100Z
LAST-MODIFIED:20230309T141718Z
UID:22604-1680082200-1680093900@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: From Ideas to Adoption: Marketing and Market Access Strategies for Life Science Innovators
DESCRIPTION:Join us for this workshop hosted by the University of Leicester Life Sciences Accelerator (LLSA). You will learn the key skills and strategies to bring your life science innovations to market and drive adoption in a complicated sector. The workshop will take place at Charnwood Campus\, Loughborough on 29 March 2023. Refreshments and lunch will be provided on the day. \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY \nThe workshop consists of two sessions:\n\nContextualising your Idea – Marketing Fundamentals: \n\nHelping you to understand how to create and articulate value for your customers by offering them innovations that meet the needs of the customer and end users in the life sciences sector. The session will provide you with skills on how to research your market\, position your idea and freedom to operate in a competitive market. \n\nShaping the Market for Adoption – Market Access Fundamentals: \n\nHelping you to understand how to shape the market opportunity for your idea and navigate the barriers to market access. This session disseminates the skills needed to explore your innovation’s market opportunity by assessing the routes to market\, developing effective communication strategies and building advocacy to drive adoption. \nAgenda:\n\n09:30 – Arrival\, Registration and Refreshments\n10:00 – Contextualising your Idea – Marketing Fundamentals (75 mins)\n11:15 – Refreshments\n11:30 – Shaping the Market for Adoption – Market Access Fundamentals (75 mins)\n12:45 – Lunch and Close\n\nThe Leicester Life Sciences Accelerator delivers free innovation support to regional life sciences SMEs to increase knowledge exchange between clinicians\, academics and local companies to accelerate product development in partnership with the Midlands Engine and is part funded by the European Regional Development fund.
URL:https://staging.medilinkmidlands.com/event/in-person-event-from-ideas-to-adoption-marketing-and-market-access-strategies-for-life-science-innovators/
LOCATION:Charnwood Campus  Loughborough\, LE11 5RB\, Charnwood Campus Loughborough\, Loughborough\, LE11 5RB\, United Kingdom
CATEGORIES:Medilink Midlands Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230328T130000
DTEND;TZID=Europe/London:20230328T140000
DTSTAMP:20260408T154021
CREATED:20230322T152931Z
LAST-MODIFIED:20230328T080419Z
UID:22797-1680008400-1680012000@staging.medilinkmidlands.com
SUMMARY:EMAHSN Innovation Academy - Live Q&A - Module I: Considerations for Spread and Adoption
DESCRIPTION:PLEASE NOTE: We are aware that some people have recently experienced issues registering for / logging into their EMAHSN Innovation Academy account. We believe this issue to now be resolved\, but please email teresao@medilinkmidlands.com if you have any difficulties registering for this module. \nThe East Midlands Academic Health Science Network Innovation Academy is open to anyone to register. Once registered\, participants will have access to a range of modules\, each including a webinar\, live Q&A session with the experts and online resources. The webinars are on demand\, so can be accessed at any time\, with the live Q&A session for each module being scheduled throughout 2023. \nFor further details/to watch the ON-DEMAND webinar or join the live Q&A session please CLICK HERE to Sign up for the Academy and to register for this module.\nThis module explores innovation\, adoption and spread within the NHS. Tony will discuss the key factors which should be considered if your innovation is replicating another or improvement across multiple locations. He will also cover what needs to be thought about if your innovation is new to the NHS and how you can provide evidence that your product significantly improves the quality of health and care. \nTony will also give you the knowledge required for you to put a completely new innovation into practice\, all whilst making you think about the logic behind your innovation! \nPresenter\n\n\n \n\n\nTony Doyle – Managing Director\, Qbtech & NHS Innovation Accelerator Fellow 2020 \n \nJulian Patel\, Associate Director (Innovation Partnerships & Business Development)\, East Midlands Academic Health Science Network (EMAHSN) \n \nMark Dines-Allen\, Senior Programme Consultant\, EMAHSN \n \nTim Robinson\, Commercial Director\, EMAHSN
URL:https://staging.medilinkmidlands.com/event/emahsn-innovation-academy-module-i/
LOCATION:Online – GoToMeeting
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230323T090000
DTEND;TZID=Europe/London:20230323T100000
DTSTAMP:20260408T154021
CREATED:20230309T121909Z
LAST-MODIFIED:20230321T115747Z
UID:22580-1679562000-1679565600@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Selling To The NHS: How Procurement Operates
DESCRIPTION:                               \nThis online event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \nCLICK HERE TO BOOK YOUR PLACE\nOur second in the series of procurement focused webinars\, this one-hour session will be delivered by Simon Clarke\, Managing Director\, BSOL Procurement Collaborative (Procurement lead – Birmingham and Solihull ICS). Simon will share his wealth of experience working with the NHS and innovators to sell to the NHS and how the NHS procurement system operates. \nTopics covered will include: \n\nWho are BSOL Procurement Collaborative\, what do they deal with and what do they require?\nOverview of the NHS procurement operation and where BSOL Procurement Collaborative sits amongst the range of Procurement entities.\nHow should industry approach NHS procurement and what should they present to get their attention and time.\nWhere do Frameworks and National procurement fit with the BSOL Procurement Collaborative?\nWho should industry approach first and why?\nWhere does industry go wrong? Common errors and faux pas when selling to BSOL Procurement Collaborative / NHS as well as several ‘must dos’.\nRegulatory considerations\nDo BSOL Procurement Collaborative evaluate / try products? Or get engaged with Health Economics for companies?\nPlans for sustainability and net zero.\nSelling to an ICB\nOther opportunities
URL:https://staging.medilinkmidlands.com/event/webinar-selling-to-the-nhs-how-procurement-operates/
CATEGORIES:Medilink Midlands Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230316T190000
DTEND;TZID=Europe/London:20230316T230000
DTSTAMP:20260408T154021
CREATED:20211027T095016Z
LAST-MODIFIED:20230223T124437Z
UID:20138-1678993200-1679007600@staging.medilinkmidlands.com
SUMMARY:Medilink Midlands Business Awards 2023
DESCRIPTION:With thanks to our Headline Sponsors\, the University of Birmingham and the Precision Health Technologies Accelerator. \n \nThe Medilink Midlands Business Awards will once again provide a stage to showcase the very best collaborations between industry\, academia and the NHS across the Midlands. \n\n\n\n\n\n\n\n\n\nWe come together each year to celebrate the achievements of life science companies\, which for 2023 will be hosted in the Great Hall\, set in the grounds of the University of Birmingham.  A truly outstanding venue\, to complement our outstanding finalists. \nThis is a fantastic opportunity for the Midlands life science community to gather together\, celebrate and network. \nCeremony & Dinner \nThe awards ceremony will be held at the Great Hall\, University of Birmingham on Thursday 16 March 2023. \nTickets \nCLICK HERE TO SECURE YOUR TICKETS\nMember individual: £99 / Member table*: £850 \nTo receive the discounted Medilink Member rate\, you will need to enter the promotional code at checkout. If you have not received your code\, please contact info@medilinkmidlands.com \nNon Member individual: £135 / Non Member table*: £1\,200 \n*table of x 10 \nplus VAT. \nHotel Accommodation \nMedilink has a small allocation of bedrooms secured at The Edgbaston Park Hotel. Please get in touch if you would like to secure your bedroom(s) at info@medilinkmidlands.com.
URL:https://staging.medilinkmidlands.com/event/medilink-midlands-business-awards-2022-2/
LOCATION:The Great Hall\, University of Birmingham\, Birmingham\, B15 2TN\, United Kingdom
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Medilink Midlands":MAILTO:zoeh@medilinkwm.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230314T093000
DTEND;TZID=Europe/London:20230314T113000
DTSTAMP:20260408T154021
CREATED:20230217T072641Z
LAST-MODIFIED:20230223T120139Z
UID:22278-1678786200-1678793400@staging.medilinkmidlands.com
SUMMARY:Selling into the NHS & Understanding your Market
DESCRIPTION:This online event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \nCLICK HERE TO BOOK YOUR PLACE\nThis webinar will provide you with an overview of the fundamental steps you need to take to  understand your market\, and your customer (NHS). Our guest speakers will share their expert knowledge in selling and preparing businesses to gain access to and sell into the NHS and health care providers. Offering advice and guidance on what is required by the NHS and others to initiate and make a sale of medical innovation. \nHear from Kate Pym\, Managing Director of Pym’s Consultancy Ltd who will cover: \n\nTimeline considerations\n\nMarket evaluation and assessment\nCustomer discovery\nFunding\nMarketing\nSales\nProduct development pipeline\nExit strategy\n\n\nUnderstanding Your Market\n\nStructures and services within the NHS\nIntegrated Care – ICS\nMarket entry points\nCompetitor analysis\nMarket size\nMarket value\nQoF\, CQUINS\, PbR\, national strategies\nInternal market competition (NHS vs private work)\n“it’s different here” – working at a trust level\n\n\nUnderstanding Your Customer\n\nFocusing on a point of access\nPosition of product/service in clinical pathway\nIdentifying buyers and stakeholders\nIncentives and drivers for stakeholder\nBudgets and autonomy\n\n\n\nOur second guest speaker\, Bob Roopra\, Managing Consultant of Roopra Medtech Consulting\, will expand on this subject\, and offer real life examples and re- affirm\, ‘it’s all about the plan!’ \nIncluding: \n\nPreparing a business to sell its new innovations into the NHS\nKey items a company must consider\nExamples of big and small medtech business – their success and lessons learnt\, and how the correct approach and preparation can lead to benefits\, such as funding and investment.\nSteps to successful launches and sales. \n\nSpeaker profiles: \nKate Pym AMIHM (mid)\, Managing Director of Pym’s Consultancy Ltd \nPym’s Consultancy Ltd is an independent consultancy providing services for SMEs and universities supporting grant applications\, responses to tender and commercialisation \nKate has over 25 years’ experience of working in Health and Social Care for companies\, including Allergan Inc.\, AstraZeneca\, Mitie and Baxter Healthcare. With a focus on innovative products and services. She has worked across the NHS\, public\, private and third sectors to produce patient-centred\, high quality\, outcome based services and facilitate the market entry and growth of new products. \nKate’s experience covers: Product launches\, writing winning bids\, working with commissioners to model population outcomes\, designing\, selling and mobilization of new health\, social care and integrated services. She has a clear focus on outcomes and what is required to demonstrate them\, with a view to market entry\, extension and expansion of constructive innovation. \nBob Roopra MBA FCMI\, Managing Direcor of Roopra Medtech Consulting Ltd. \nBio/photo to follow.
URL:https://staging.medilinkmidlands.com/event/sellingintothenhsknowyourmarketrket/
LOCATION:Online
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230307T093000
DTEND;TZID=Europe/London:20230307T113000
DTSTAMP:20260408T154021
CREATED:20230214T135008Z
LAST-MODIFIED:20230228T142302Z
UID:22214-1678181400-1678188600@staging.medilinkmidlands.com
SUMMARY:WEBINAR: A Practical Guide to Achieving Net-Zero – What it Means for the Healthcare Supply Chain
DESCRIPTION:This online event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \n  \nFollowing on from the face-to-face event held in December\, this online event will continue to examine the ambitious sustainable goals set out by the government and the NHS\, and how you\, as a life sciences or health care organisation\, need to adapt to meet the requirements of the customer (NHS). Plus\, it will explore how you can lead the way to achieving net zero and a sustainable organisation. \nAttend this free session to find out: \n\nOverview of NHS needs\nSupport available from the AHSN\nExamples of innovation driving greener healthcare\nHow to measure and reduce your own emissions and save energy costs\nHow to reduce emissions and save energy costs.\n\nOur panel of guest speakers include: \n\nHelen Black\, Transformation and Net Zero Delivery Lead\, NHS England – Midlands\nPete Waddingham\, National NetZero Lead\, The AHSN Network\nOlivia Simpson\, CEO & Co-Founder\, SymbioTex\nDavid Abosch\, Director\, Cognition Cloud\nAdam Wright\, Chief Operating Officer\, Zellar\n\nTo secure your free place click here\nSpeaker company profiles: \nThe AHSN Network \nAcademic Health Science Networks (AHSNs) bring together the NHS\, industry\, academic\, third sector and local organisations. Our collaboration ensures innovations\, improvements and best practice benefit more patients faster. \nOur national innovation pipeline features more than 1\,200 proven technologies ready to be matched to local health and care challenges. \nSymbioTex is a west midlands based company started by two university of Wolverhampton students. It focuses on utilising seaweed and waste biomass to produce home compostable semi ridged bioplastics – with the goal of producing class 1 medical devices such as inhalers\, pregnancy test and other diagnostic tests. \nCognition Cloud helps organisations to understand the environmental impact of their Information Technology and provides services to help them mitigate it. \nCognition Cloud is able to provide organisations a baseline measurement of the embedded GHG emissions in their desktops and laptops. Their services then help them to significantly cut these emissions over time. \nZellar is the UK’s leading sustainability platform\, helping businesses on their journey to Net Zero in the fastest\, most efficient and cost-effective way. \nReducing energy usage in the current climate\, even by 20%\, is likely to have a significant impact on businesses’ bottom line. Every business needs to become sustainable; their customers\, employees and stakeholders will be demanding it. \nThe Midlands is leading the way\, hear how the Zellar platform can support your business and the planet.
URL:https://staging.medilinkmidlands.com/event/webinar-a-practical-guide-to-achieving-net-zero-what-it-means-for-the-health-care-supply-chain/
LOCATION:Online
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Medilink Midlands":MAILTO:zoeh@medilinkwm.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230216T100000
DTEND;TZID=Europe/London:20230216T110000
DTSTAMP:20260408T154021
CREATED:20230124T080337Z
LAST-MODIFIED:20230203T111733Z
UID:21978-1676541600-1676545200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: The Future of AI in Life Sciences
DESCRIPTION:  \n  \n  \nThis online event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \nAI is firmly on the agenda within the life sciences sector\, whether it’s mining data for new drug/target interactions\, or collaborating to improve the diagnostic capability of HealthTech solutions. \nIn this ever moving landscape innovators need to keep ahead of the legal landscape and know whats coming. \nJoin James Fry\, Head of Life Sciences and Partner\, Mills & Reeve on how we are seeing Artificial intelligence (AI) being applied within the life sciences sector and what’s on the horizon. \nCLICK HERE TO BOOK YOUR FREE PLACE\nThis session will cover: \n\nHow we are seeing advanced technologies e.g. AI\, being applied within the life sciences sector;\nThe legal landscape e.g. IP and regulatory issues; and\nHorizon scanning (what’s coming up).\n\nFollowing the presentation\, you will have the chance to put your questions to James. \nDURATION: 1 hour \nSpeaker Profiles: \n \nJames Fry\, Head of Life Sciences and Partner at Mills & Reeve \nJames heads the firm’s fast growing\, multi-disciplinary life sciences practice and focuses exclusively on this sector. The practice supports clients in the pharma and biotech\, medical device\, diagnostic\, medtech and digital health sub-sectors. James’ own practice focuses on intellectual property\, commercial contracting and regulatory work. \n 
URL:https://staging.medilinkmidlands.com/event/aifuturelifesciences/
LOCATION:Online
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Medilink Midlands":MAILTO:zoeh@medilinkwm.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230215T180000
DTEND;TZID=Europe/London:20230215T200000
DTSTAMP:20260408T154021
CREATED:20221220T113854Z
LAST-MODIFIED:20221220T123021Z
UID:21633-1676484000-1676491200@staging.medilinkmidlands.com
SUMMARY:Midlands Meet-Up Networking Event
DESCRIPTION:     \nWe are delighted to announce details of the OBN Midlands-focused networking evening on 15 February 2023\, organised in collaboration with our sponsor Penningtons Manches Cooper​ and co-promoted by ourselves and The West Midlands Healthtech Cluster. \nThe purpose of the evening is to showcase the West Midlands’ strong and growing life sciences ecosystem and get to know some of the most innovative R & D companies in the region. \nIf you would like to find out more and build your Midlands network\, please click here to book your complimentary ticket. The event starts at 18.00\, with a drink on arrival and Pizza during the evening. \n 
URL:https://staging.medilinkmidlands.com/event/obn-midlands-meet-up/
LOCATION:Lost and Found\, Birmingham\, B2 5RS
CATEGORIES:Medilink Midlands Event,Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230209T100000
DTEND;TZID=Europe/London:20230209T110000
DTSTAMP:20260408T154021
CREATED:20221216T083732Z
LAST-MODIFIED:20230203T114611Z
UID:21607-1675936800-1675940400@staging.medilinkmidlands.com
SUMMARY:Beginner's Guide to developing and releasing a new Medical Device or IVD
DESCRIPTION:  \n  \n  \nThis free-to-attend event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \nMedical devices and IVDs are a highly regulated industry\, and the regulatory considerations should be considered at the earliest stages of your strategic planning to help ensure that your products can be successfully approved and commercialised. \nThe webinar will provide a high level overview of the critical considerations and overview of the key steps needed from initial planning through to successfully selling the product after regulatory approval. \nThe webinar will cover the following focus areas; \n\nRegulatory planning as part of your product get-to-market strategy\nConsiderations for product design and development\nNavigating the regulatory approval process\nCommercial launch and beyond – demonstrating continuing safety\, performance and compliance to keep your product approval.\n\n CLICK HERE TO SECURE YOUR PLACE\nTarget audience \n\nThis webinar training session is aimed at companies looking to or currently developing a new medical device and explores the critical strategic\, operational and industry specific considerations necessary for successful commercialisation of a medical device or IVD product\, with a focus on the regulatory and legal compliance environment.\nThis webinar is aimed at business leaders\, product developers\, software developers\, technical managers\, quality and regulatory professionals.\n\n  \nTimothy Bubb\, Technical Director\, IMed Consultancy \nTim Bubb is a Principal Consultant and heads up the medical device consulting team at IMed Consultancy. Tim specialises in high-risk active therapeutic medical devices\, software\, digital health\, and AI/ Machine learning\, such as defibrillators\, ventilators\, and clinical decision support software. Tim has a wealth of experience in medical device quality\, regulatory\, clinical\, and design engineering fields\, having held senior industry positions in both multinational and SME manufacturers with overall responsibility for ensuring product legal compliance from concept through to regulatory approval\, and successful commercialisation. \nIMed Consultancy is a Medical Device and IVD specialist Regulatory and Quality consulting company\, helping manufacturers achieve and maintain regulatory approvals for their products and quality management systems through a variety of consulting and representation services. \n 
URL:https://staging.medilinkmidlands.com/event/beginners-guide-to-developing-and-releasing-a-new-medical-device-or-ivd/
LOCATION:Online
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Medilink Midlands":MAILTO:zoeh@medilinkwm.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230131T093000
DTEND;TZID=Europe/London:20230131T133000
DTSTAMP:20260408T154021
CREATED:20221220T095559Z
LAST-MODIFIED:20230120T144606Z
UID:21625-1675157400-1675171800@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Designing DNA: Exploring the Possibilities of the BioXp 3250
DESCRIPTION:     \nIf you were able to print genetic code\, what opportunities would be open to you? How could you use this technology to further develop your innovation and improve future health outcomes? \nThese are the questions we’re inviting you to consider at our latest event\, organised in partnership with the Medical Technologies Innovation Facility (MTIF). Join us on-site at MTIF \, located on Nottingham Trent University’s Clifton Campus\, where the MTIF team\, alongside the BioXp’s developers at Telesis Bio\, will introduce you to their latest piece of kit\, the BioXp 3250. This state-of-the-art machine\, in the words of its developers\, “supports applications ranging from building\, cloning\, and amplifying gene fragments to constructing DNA“. \nThis free-to-attend morning event aims to bring together innovators\, researchers and facilitators to explore the potential applications of this equipment.  An invaluable asset for the life sciences community in our region and beyond\, the BioXp 3250 is available now for collaborators looking to push the boundaries of the possible – let’s open those conversations! \nThis is intended to be an open forum and you are welcome to propose potential applications for the BioXp 3250 in any field. However\, we’re particularly keen to hear your ideas relating to the following areas: \n\nmRNA as vaccines\nmRNA as cancer treatments\nDNA code for genetic modification\n\nBOOK YOUR FREE SPOT NOW\nThe event will begin with a tour of the facility including a showcase of the BioXp 3250. This will be followed by a couple of short presentations providing an overview of its capabilities and highlighting some of its current applications. Then it’s over to you\, as we open a discussion of the opportunities the device opens up\, aiming to spark collaborative connections that develop beyond the session. \nSecure your place today for an event that will not only consider the potential of the BioXp 3250\, but will also further strengthen the collaborative networks within the region. \nEvent details\n\n09:30 – Registration and refreshments\n10:00 – Welcome and introductions from Medilink and MTIF\n10:05 – Tour and BioXp 3250 demo\n11:00 – Networking and refreshments\n11:30 – Presentation from Telesis Bio on current applications of the BioXp 3250\n11:45 – Q&A + Break-out sessions + Group discussion on potential future applications\n12:30 – Lunch & networking\n13:30 – Close
URL:https://staging.medilinkmidlands.com/event/designing-dna/
LOCATION:Medical Technologies Innovation Facility (MTIF)\, Clifton Campus\, NTU\, Clifton Lane\, Nottingham\, Nottinghamshire\, NG11 8NS
CATEGORIES:Featured,Medilink Midlands Event
ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230126T093000
DTEND;TZID=Europe/London:20230126T133000
DTSTAMP:20260408T154021
CREATED:20221220T104000Z
LAST-MODIFIED:20230224T103133Z
UID:21627-1674725400-1674739800@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Health Data Science: The Real-World Opportunities and Challenges
DESCRIPTION:          \n  \nOur next event organised in partnership with the Leicester Life Sciences Accelerator (LLSA) at the University of Leicester focuses on the sector’s hot topic of 2023 – health data science. The event will be held at Space Park\, Leicester and brings together academics\, clinicians and industry to explore the breadth of opportunities in this field\, as we move increasingly towards digital solutions. Yet the session also unpacks the significant challenges in this area\, considering the barriers to gaining access to health data and utilising this data to develop successful digital solutions or service improvements in the real world. \nOur first panel will include researchers and decision makers in this area\, who will outline the latest academic and clinical health data science contexts. The second panel of presentations will feature talks from companies working in and with health data science\, to extend our discussion of its real-world applications and opportunities for industrial and commercial partners. \nProgramme\n09:30 – Delegate arrival\, registration & refreshments \n09:55 – Introduction to the LLSA from Professor Toru Suzuki\, Academic Lead for the LLSA and Chair of Cardiovascular Medicine and Honorary Consultant Cardiologist\, University of Leicester (Video) \n10:00 – Panel 1 – Professor Tim Coats\, Dr Rob Free\, Dawn Plummer + Q&A and Panel discussion \n11:00 – BREAK – Refreshments and networking \n11:30 – Panel 2 – SME Showcase – Methods Analytics (Richard Oakley)\, iethico (Debra Ainge)\, Vuit Online (Clare Higgins)\, CheckUp Health (Fungai Ndemera) + Q&A and Panel discussion \n12:30 – Lunch and networking \n13:30 – Close \n  \nSpeaker Profiles\n \nProfessor Tim Coats\, Professor of Emergency Medicine\, University of Leicester \nPresentation Title: “NHS Data: What\, Where and How” \nTim Coats trained in Emergency Medicine in Leeds and London\, developing a particular interest in pre-hospital trauma care\, and completing an MD thesis in 1996 on using AI methods to incorporate of patterns of change in physiology in a predictive model of outcome following injury. He trained in prehospital care with the London Helicopter Emergency Medical Service from 1990 to 1996 \nFollowing appointed as a Senior Lecturer at Barts and The London in 1996 with consultant responsibility for the London HEMS service\, he moved to the University of Leicester as Professor of Emergency Medicine in 2003. He is a past Chair of the College of Emergency Medicine Research Committee\, past Chair of the NIHR National Specialist Group for Injuries and Emergencies\, and currently Chairs the Trauma Audit and Research Network (TARN). In 2022 he became a NIHR Senior Investigator. His research interests are changes in coagulation following major trauma\, artificial intelligence in healthcare ‘big data’ applications\, and non-invasive monitoring in the diagnosis of sepsis in emergency care. \n \nDr Rob Free\, Lecturer in Health Data Science at University of Leicester and Director of Informatics at Leicester Biomedical Research Centre \nPresentation Title: “Data Science Opportunities in the Leicester BRC” \nRob Free is a Lecturer in Health Data Science at the University of Leicester and the Director of Informatics for the NIHR Leicester Biomedical Research Centre (BRC). His own research focuses on the use of advanced data science (including artificial intelligence and machine learning) to develop and translate models and technologies into data-driven approaches for improving healthcare outcomes. As Director of Informatics\, he is overseeing the BRC’s new Health Informatics Platform which endeavours to facilitate and develop exciting multi-disciplinary collaborations and partnerships. \n \nDawn Plummer\, Digital Lead\, East Midlands Academic Health Science Network \nPresentation Title: “EMAHSN – Who we are\, how we support innovators and current digital trends in local NHS” \nDawn Plummer is the Digital Lead at the EMAHSN\, working within the Innovation Pipeline Delivery team\, seeking to match innovations with known needs in our local networks. Dawn has experience supporting innovators to partner with NHS organisations to trial solutions\, with an overall aim to support embedding innovations as ‘business as usual’ whilst collecting evidence and data to support adoption and spread into other local Trusts. The digital team deliver EMAHSN’s Digital Health Accelerator programme\, which for 2023 is focussing on workforce innovations as a key focus locally\, based on conversations with key stakeholders. \n \nRichard Oakley\, Director of Data Science and AI\, Methods Analytics \nPresentation Title: TBC \nRichard is Director of Data Science and AI at Methods Analytics. By background a technical architect with over a decade’s experience in the public and private sector\, overseeing all of Methods Analytics’ data science and AI work including that in health & care. \nHe specialises in healthcare improvement projects that utilise or advance data-orientated decision-making\, architecting solutions in a variety of open-source and proprietary technologies. He is an advocate for greater application of data science in health & care\, working to promote the use of machine learning\, predictive modelling\, simulation and population health management techniques in forms that are accessible and sustainable within the NHS. \nHe has worked with central\, regional and local health organisations across primary\, secondary and tertiary care across the UK and internationally. His recent project work incorporates the full suite of information science from helping to implement and embed new data science functions within large organisations through to ontology creation\, semi-clinical NLP classifiers\, risk modelling and capacity & flow simulations. \n \nDr Debra Ainge\, CEO\, iethico \nPresentation Title: Drug Shortages: A Global Crisis \nDebra combines broad international experience in the healthcare industry in R&D\, Technology\, and the pharmaceutical service sector across UK and internationally\, with a record of delivering growth both organically & through M&A. She has led organisations from start-up to +5000 staff and has an extensive industry network built through the development of strong relationships across pharma\, biotech & technology. Debra is a certified member of the Institute of Directors\, holds several non-executive roles and has a PhD from Newcastle University. \n \nClare Higgins\, Marketing and Sales Manager\, VUIT Online \nPresentation Title: Actionable Insights – A Rare and Precious Thing \nFor many years\, Clare enjoyed a successful career in the drinks industry\, working up from PA to the MD through to Operations Manager\, leading a team of 7 staff rising to a maximum of 450 staff over the period.  Clare joined VUIT in May 2021 as Marketing and Sales Manager\, tasked with commercialising the platform and developing the company structure. To date\, VUIT has received considerable interest and recognition within the sector\, and continues to open new sales channels. \n \nFungai Ndemera\, Nurse\, Multi-entrepreneur\, Health Tech Disruptor and Founder\, CheckUp Health  \nFungai is the tech founder of CheckUp Health\, the only health AI-driven NHS approved hybrid multilingual care delivery platform combining remote monitoring in-home offering connectivity points to clinicians and professionals. Empowering the patient to take control with a culturally competent secure app for personal health tracking and monitoring​ and ​BAME engagement metrics\, helping healthcare organisations\, from GP practices to corporate organisations\, monitor proactively and effectively support patients from various backgrounds by offering multilingual options​.​ She is the creator of the ‘all dots’ digital transformation model. \nHer health tech brand\, CheckUp health\, received £43k support from the UK government’s highly competitive sustainable innovation fund. Through this company\, Fungai helps individuals have access to a user-friendly app and desktop versions for all ages to start managing their health and reduce the need to see a GP. Some of her initiatives were supported by the president’s office of the Zimbabwe Ministry of Information. Fungai’s goal is to improve digital healthcare knowledge transfer with CheckUp Health UK.
URL:https://staging.medilinkmidlands.com/event/llsa-healthdatascience/
CATEGORIES:Featured,Medilink Midlands Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230124T100000
DTEND;TZID=Europe/London:20230124T113000
DTSTAMP:20260408T154021
CREATED:20201221T141516Z
LAST-MODIFIED:20230113T165304Z
UID:21456-1674554400-1674559800@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Grant Funding for your Innovation
DESCRIPTION:  \n \n  \nThis event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \nThe WMAHSN\, Medilink Midlands and TBAT Innovation invite you to attend this free Grant Funding webinar. \nTBAT Innovation Ltd provide an in-depth look at the Grant Funding landscape\, to fund the development of new technology in the Health & Life Sciences sector. \nGrant Funding is available through many funding bodies – including Innovate UK\, NIHR and SBRI Healthcare – to accelerate innovation in the UK by de-risking highly innovative research and development projects. \nCurrent opportunities have up to £25 million available for businesses to apply for\, but the competition can be fierce – knowing how to apply is essential. \nIn this webinar\, we will cover: \n\nGrant Funding Landscape\nRegular competitions for Health & Life Sciences technology\nHow to find funding\nApplication best practice\nTop Tips\nHow TBAT can help\n\nFollowing the presentation\, TBAT will be available for an open forum Q&A session\, and the opportunity to book one-to-one consultations\, for any follow-on or confidential questions about applying for Grant Funding. \nCLICK HERE TO SECURE YOUR PLACE\nSam Stephens – Director\n\nSam founded TBAT in 2002\, evolving the business over a five-year period into the innovation-driving consultancy it is today. \nWith a passion for engineering\, as well as a background as an Aerospace engineer\, Sam’s deep experience within innovation has played a huge role in growing various businesses\, as well as TBAT. \n\nTBAT Innovation\nTBAT Innovation Ltd are a value-led independent consultancy with over 19 years’ experience working with technology & research and development organisations all over the UK to fund their innovation. Their innovation support services include; Grant Funding\, R&D Tax Credits\, Video Game Tax Relief\, Capital Allowances\, SEIS/EIS and Patent Box.
URL:https://staging.medilinkmidlands.com/event/grantfundinginnovation/
LOCATION:Online
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230118T130000
DTEND;TZID=Europe/London:20230118T140000
DTSTAMP:20260408T154021
CREATED:20221129T132610Z
LAST-MODIFIED:20230112T102603Z
UID:21445-1674046800-1674050400@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Maximising Impact through Academic and Industry Collaboration
DESCRIPTION:     \nThe next in our series of events organised in partnership with Arise Innovation Hubs\, part of Anglia Ruskin University\, focuses on the key role that academic and industry partnership can play in maximising the impact of your research and/or innovation. \nThe benefits are\, of course\, considerable for both sides of the partnership. This online webinar explores these benefits\, providing tangible guidance for those keen to collaborate\, as well as case studies from those who have already established successful partner projects. \nBOOK YOUR FREE PLACE TODAY\nThe session will open with a talk from Caroline Sykes from the Medilink Midlands Innovation Adviser team. Drawing on her extensive experience across the sector\, Caroline will be highlighting both the reasons and routes for establishing\, developing and making the most of academic and industry collaborative opportunities. \nWe’ll also hear a joint presentation from Jenny Murray\, CEO of Life Science Group (LSG) and Abhimanyu Bose\, Knowledge Exchange Executive for Coventry University\, who will be sharing the story of their successful Knowledge Exchange Partnership (KEP)\, through which they co-developed CellShip\, a cell transport system without a cold chain requirement. The project was ratws ‘Outstanding’ by the Knowledge Transfer Network (KTN) – the highest rating – and also secured them a finalist spot in the in Medilink Midlands Business Awards 2022. \nOur final presentation will be delivered by Joe Lillis and Jorge Madeira Marques Pinto\, lead researchers on a collaborative project between Anglia Ruskin University and Italian company\, La Fattoria la Vialla\, exploring the potential health\, performance and sustainability benefits of olive oil products developed at their organic-biodynamic farm. \nAs well as an opportunity to showcase current successful projects\, this session lays the foundations for a series of support sessions that Medilink Midlands will be running in partnership with the Arise Innovation Hubs and will be your opportunity to find out more information. \nClick the link above to secure your place for this practical and informative online session.
URL:https://staging.medilinkmidlands.com/event/arise-academic-and-industry-collaboration/
LOCATION:Online
CATEGORIES:Featured,Medilink Midlands Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230110T100000
DTEND;TZID=Europe/London:20230110T113000
DTSTAMP:20260408T154021
CREATED:20201112T074241Z
LAST-MODIFIED:20221221T084532Z
UID:18432-1673344800-1673350200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: So you want to make a digital medical device? beginners guide
DESCRIPTION:This event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \nThe following course has been devised and presented by AcclaimBiomedical Consulting\, Medilink Midlands and the WMAHSN to offer a rich and rewarding training experience. \n\nSoftware is playing an increasingly important role in the medtech sector\, we see developments in smart devices\, embedded software and wearable healthcare technology. We also see that European Regulations are developing to address this technology with increased scrutiny and specific requirements for these products .\nThis webinar training session is aimed at all companies developing and maintaining these types of products and explores the pathway to compliance .\n\nThe top 10 tips \nThe course will cover the following focus areas \n\nPlanning is Critical\nUnderstand thoroughly the intended use\, user and use environment\nRisk Classify your product\nConsider local requirements (GSPR)\nFollow a documented process for product development IEC62304\nAppropriate selection of development environment\nConsider user interface (Usability)\nHow will this be maintained\nConnections\nCyber security\n\nLearning Objectives \n\nWorking with quality and regulatory teams including demonstration of design process control:\nStudy the application of recognised standards and good practice as well as documentation expectations.\nExplore the need for risk management and human factors engineering in this product sector.\n\nCLICK HERE TO SECURE YOUR FREE PLACE\nSpeaker Profile: \n\nRichard Young\, Managing Director\, AcclaimBiomedical Consulting Ltd\nRichard has an extensive background in regulatory affairs in addition to GMP (quality assurance)\, GLP (laboratory testing)\, and GCP (clinical). Spanning over two decades\, these core skill areas have been developed with experience in products ranging from class 3 devices such as Orthopaedic implants (IIb) neurological robots\, through electromedical devices such as infusion systems and cardiovascular products. \nRichard brings a blend of pragmatism and experience to these disciplines that facilitate insightful problem-solving approaches as well as solid solutions. \nRichard’s skills and experience includes such areas as the development and implementation of effective quality management systems\, auditing to ISO and FDA QSIT standards\, and operating at national and international level through industry associations including Eucomed\, ABHI\, and ABHI Technical Policy Group. \n 
URL:https://staging.medilinkmidlands.com/event/digitalmedicaldevices-2/
LOCATION:Online
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Medilink Midlands":MAILTO:zoeh@medilinkwm.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221129T100000
DTEND;TZID=Europe/London:20221129T110000
DTSTAMP:20260408T154021
CREATED:20201221T141516Z
LAST-MODIFIED:20221122T081806Z
UID:21040-1669716000-1669719600@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Getting Your Healthcare app reviewed and accredited
DESCRIPTION:           \n  \nThis event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \nThe WMAHSN\, Medilink Midlands and ORCHA invite you to attend a free digital health webinar on Tuesday\, 29 November at 10:00 am – 11:00 am. \nORCHA is the world-leading health app evaluation and advisor organisation\, helping governments\, health\, and social care organisations to choose and deliver health apps that will safely make the biggest impact to improve outcomes. \nThis session will cover an introduction to the importance of digital health tools\, and the current digital health landscape\, with Paul Weston\, Review & Accreditations Director at ORCHA. \nIncluding: \n\nUpdate on the current digital health landscape\nThe importance of getting app reviews and accredited\nWhat it involves\nGetting yourself ready to do it a\nHow to make sense of it all!\nSources of support\n\nThere will be time at the end of the presentation to ask Paul questions. \nPLEASE CLICK HERE TO SECURE YOUR PLACE\n\nPaul S Weston is passionate about keeping people out of hospital. As Review & Accreditations Director at ORCHA he gives healthcare professionals and consumers the confidence to recommend and benefit from digital health products that are safe\, effective and secure. Paul and his team of Digital Health Assessors develop and maintain Reviews in 11 countries and continually monitor and assess over 3000 products a year. \nPrior to joining ORCHA\, Paul was Chief Operating Officer at Tiny Medical Apps (Developer of top ORCHA rated asthma app the Digital Health Passport). His work led to inclusion on healthcare frameworks (LPP\, G-Cloud\, HSSF); maintaining quality assurance certification (ISO 27001/13485\, Cyber Essential Plus\, DSPT); and product deployment to over 1000 patients in 16 healthcare organisations. \nPaul’s commitment to improving health outcomes started with delivering regulation-heavy primary care developments – a journey that impacted over 275\,000 patients over 19 years leading ISO9001 certified Architecture businesses. Having seen the growing\, untenable demands of in-person healthcare provision\, in 2018 he made the decision to explore the role that digital health technology can play in reducing demand on the built environment. \nPaul is a London Tech Advocate and One HealthTech (Diversity & Inclusion) Fellow focusing on international partnerships. \n\n\n 
URL:https://staging.medilinkmidlands.com/event/webinar-getting-your-healthcare-app-reviewed-and-accredited-2/
LOCATION:Online
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221117T140000
DTEND;TZID=Europe/London:20221117T160000
DTSTAMP:20260408T154021
CREATED:20211013T080011Z
LAST-MODIFIED:20221102T143803Z
UID:20807-1668693600-1668700800@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Medilink Midlands Annual General Meeting (AGM)
DESCRIPTION:The Medilink Midlands Annual General Meeting (AGM) will take place on Thursday 17 November from 2.00 pm – 4.00 pm. \nHosted at Medilink Patron offices\, Mills & Reeve\, Birmingham. \nFollowing the formal presentations\, you will have the chance to meet and network with fellow members and representatives from the Board of Directors. \nYou will also hear from our members sharing their recent experiences and how they have benefited from their membership. \n  \nAgenda: \n14:00 – Arrival refreshment & networking \n14:20 – Welcome & notices – Professor Martin Levermore MBE DL\, Chair\, Medilink Midlands \n14:35 – Medilink Midlands update – Simon Himsworth\, Chief Executive\, Medilink Midlands \n14:55 – Member spotlight – Dave Seaward\, Projects Director\, 3P innovations \n15:10 – Member spotlight – Adam Townsend\, VUIT \n15:25 – Sustainability vision – Ben Roberts\, Innovation Advisor\, Medilink Midlands \n15:35 – Closing comments – Professor Martin Levermore MBE DL \n15:40 – Networking & refreshments \n16:00 – AGM close \n  \nWe’re looking forward to seeing our members in person and hope you can join us. \nPlease note: Non-members are welcome to attend the AGM. \nTo book your place\, please complete the online booking form below.  \n		\n					\n						\n					\n			\n						\n				\n									\n					\n						\n									BOOK NOW\n					\n					\n				\n								\n				\n					\n		\n					\n		\n				\n		\nOnce your booking form has been received a member of the events team will be in touch to confirm your place\, please note this is not an automated system.
URL:https://staging.medilinkmidlands.com/event/in-person-event-medilink-midlands-annual-general-meeting-agm-2/
LOCATION:Mills & Reeve\, 78-84 Colmore Row\, Birmingham\, B3 2AB
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221117T083000
DTEND;TZID=Europe/London:20221117T173000
DTSTAMP:20260408T154022
CREATED:20221110T133740Z
LAST-MODIFIED:20221110T133740Z
UID:21202-1668673800-1668706200@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: NIHR Biomedical Research Conference 2022
DESCRIPTION:Medilink Midlands will be exhibiting at this year’s NIHR Nottingham Biomedical Research Centre Conference\, held at the East Midlands Conference Centre. \nThe NIHR Biomedical Research Conference returns in 2022 to celebrate the BCR’s achievements since 2017. We will also be launching our new programme of research up to 2027. \nOur world-leading researchers will present their latest findings and impacts. \n\nyou can hear from national and international speakers on what’s coming next for research in the UK\nwe’ll engage the delegates and social media users in a live Research Lounge debate on the future of translational research\nwe’ll discuss what we have learned from COVID-19 research that could improve all translational research\nwe’ll showcase the work of our research Themes and introduce our new Themes\n\nIn addition to the above\, the programme includes keynote presentations from: \n\nProfessor Ian Hall\, Director\, NIHR Nottingham Biomedical Research Centre\nProfessor Matt Brown\, Genomics England\nNatalie Owen\, Head of NIHR Infrastructure Research Capacity and Growth Science\, Research and Evidence Directorate\, Department of Health and Social Care\nProfessor Sir Martin Landray\, Oxford Population Health\n\nAs well as optional workshop sessions\, panel discussions and a panel discussion. \nFor more information and to book your place\, click here.
URL:https://staging.medilinkmidlands.com/event/in-person-event-nihr-biomedical-research-conference-2022/
LOCATION:East Midlands Conference Centre\, University Park\, Beeston Lane\, Nottingham\, NG7 2RJ
CATEGORIES:Medilink Midlands Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221116T103000
DTEND;TZID=Europe/London:20221116T113000
DTSTAMP:20260408T154022
CREATED:20210505T113125Z
LAST-MODIFIED:20220922T151824Z
UID:20575-1668594600-1668598200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Grant Application Writing Masterclass
DESCRIPTION:Join TBAT Innovation Ltd for a Grant Funding Masterclass\, delving into how to write a successful grant application for Innovate UK. \nKnowing how to write your grant funding application is the most important part of applying for innovation funding. \nMany competitions have success rates of below 10%; therefore\, your application needs to stand-out\, showcase your innovation and demonstrate your knowledge and expertise\, all within tight word-limits. \nThrough years of successfully helping businesses just like yours\, apply for Innovate UK funding competitions\, TBAT are experts in writing successful funding applications that will capture the assessor’s attention and highlight why your innovative project should be funded! \nDuring this 1-hour masterclass\, TBAT will cover: \n\nThe Innovate UK application form\nHow to answer each question\nTheir top tips for applying for Innovate UK funding\nWhat to do if you need help applying\n\nThis is great opportunity to learn how to apply for current Innovate UK funding competitions such as the Smart Grants and the Bio-Medical Catalyst and secure up to 70% of your project costs via these opportunities. \nBOOK YOUR PLACE TODAY\nSpeaker Profiles \nVincent Seddon – Commercial Director \nVincent Seddon joined TBAT in 2019 to head up business development after spending 10 years supporting Corporate clients to plan and grow their businesses as well as mentoring and coaching local business managers with the Barclays Business Bank. \nEsther Lawrence – Business Development Manager \nEsther joined TBAT in May 2021 having spent 25 years working in technology sales helping take products and services to market. She’s worked with start-ups\, manufacturers\, distributors\, and Go-to-markets specialist. She’s witnessed first-hand the struggles companies go through to gain funding to develop and innovate their new tech and services\, which is why she’s excited to be part of TBAT to help guide innovative organisations through the R&D funding landscape. \nTBAT Innovation\nTBAT Innovation Ltd are a value-led independent consultancy with over 19 years’ experience working with technology & research and development organisations all over the UK to fund their innovation. Their innovation support services include; Grant Funding\, R&D Tax Credits\, Video Game Tax Relief\, Capital Allowances\, SEIS/EIS and Patent Box.
URL:https://staging.medilinkmidlands.com/event/webinar-grant-application-writing-masterclass-22/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final-transparent.png
ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221115T100000
DTEND;TZID=Europe/London:20221115T113000
DTSTAMP:20260408T154022
CREATED:20220623T111225Z
LAST-MODIFIED:20221114T072206Z
UID:19499-1668506400-1668511800@staging.medilinkmidlands.com
SUMMARY:ONLINE: Creating a Secure Future for your Life Sciences Company through Robust Business Strategy and Planning
DESCRIPTION:****Please note this event will now take place online **** \n  \nThis event\, organised with patron Shakespeare Martineau in partnership with Ampa\, will now take place online. \nIf you are selling into the NHS or other healthcare providers\, no matter what your product or service\, the security of your business is critical. This session offers guidance on creating a secure future for your life sciences company through robust business strategy and planning. \nThe online session will cover: \n\nHow to secure your business and supply chain against cyber attacks\, and how to mitigate risk\nHow to ensure solid fundamentals are in place throughout the lifecycle of the business – inception\, growth and exit\nFunding and investment for growth;\nExit strategy and valuation and exit options i.e.\, trade or PE sale\, management buyout of Employee Ownership Trust.\n\nThe case study-led event looks at a real-life example of a business lifecycle\, from raising finance and receiving investment to reviewing strategic options\, preparing for sale and how to achieve maximum value while also considering how to minimise associated risk and avoid potential pitfalls. Follow the links below to read the case study material in advance and to view full speaker profiles. \nCase Study \nSpeaker Profiles \nThe Ampa team of experts will be offering one-to-one advisory appointments\, and will provide advice and guidance on: \n\nFunding – outsourced contracts\, site acquisitions\, product development\, refinancing existing debt (over draft and property term loans)\, lending and additional funding; Potential investors\, investment.\nManagement – share options\, discretionary bonuses.\nCommercial – contractual\, IP\, Employment and cyber security/data considerations.\n\n\n		\n					\n						\n					\n			\n						\n				\n									\n					\n						\n									BOOK NOW\n					\n					\n				\n								\n				\n					\n		\n					\n		\n				\n		\nShakespeare Martineau are proud Patrons of Medilink Midlands. To read more\, please click here. \n 
URL:https://staging.medilinkmidlands.com/event/protectingyourlifesciencesbusiness/
LOCATION:Online
CATEGORIES:Featured,Medilink Midlands Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221110T093000
DTEND;TZID=Europe/London:20221110T163000
DTSTAMP:20260408T154022
CREATED:20220812T092525Z
LAST-MODIFIED:20220824T150316Z
UID:19960-1668072600-1668097800@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Open House: Cross-sector opportunities for Midlands SMEs
DESCRIPTION:Four business-led sector organisations are coming together to host a unique Cross Sector Open House. The event is being delivered by Aerospace Unlocking Potential*\, which is led by the University of Nottingham in Partnership with the Midlands Aerospace Alliance\, and supports companies to diversify into and out of aerospace and aviation. \nMidlands Aerospace Alliance\, Medilink Midlands\, Rail Forum and the Motorsport Industry Association will share their knowledge of recent developments and current and future opportunities for SMEs across the Midlands. Case study SMEs will demonstrate how they have successfully diversified into other sectors. \nTeams from the four organisations will be on hand to field enquiries about their sector. Additional support is available through Aerospace UP for any SMEs wanting to diversify into (or from) aerospace\, aviation\, space or advanced air mobility. \n                       \nWe know that great ideas and technologies from businesses that are experts in one sector can be applied to solve problems in another – this event is designed to help things along by providing a forum for Midlands companies to network across all sectors and learn from one another. \nThis event is funded by Aerospace Unlocking Potential which enables Midlands SMEs to attend for free (please check criteria at booking page). \nTopics to include (all still to be confirmed) \n\nDevelopments / Opportunities in aerospace\nDevelopments / Opportunities in rail\nAdvanced Air Mobility – future supply chain opportunities\nDevelopments / Opportunities in motorsport\nSpace – future supply chain opportunities\nDevelopments / Opportunities in MedTech\nAerospace UP funding and available support\nSME case studies\nPanel Q&A sessions\nNetworking sessions\n\nDate: Thursday 10th November 2022\nVenue: British Motor Museum\, Banbury Road\, Gaydon\, Warwickshire\, CV35 0BJ (Free museum ticket included) \nBook your place here
URL:https://staging.medilinkmidlands.com/event/in-person-event-open-house-cross-sector-opportunities-for-midlands-smes/
LOCATION:British Motor Museum\, Banbury Road\, Gaydon\, Warwickshire\, CV35 0BJ
CATEGORIES:Featured,Medilink Midlands Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221027T100000
DTEND;TZID=Europe/London:20221027T140000
DTSTAMP:20260408T154022
CREATED:20220929T121751Z
LAST-MODIFIED:20230630T075007Z
UID:20633-1666864800-1666879200@staging.medilinkmidlands.com
SUMMARY:HYBRID EVENT: Digital Technologies for Positive Mental Health and Wellbeing
DESCRIPTION:       \nTo mark the launch of the collaborative project between Medilink Midlands and the ARISE Innovation Hub\, part of Anglia Ruskin University\, we will be hosting an exciting hybrid event on Thursday 27th October. The event will be held at Harlow Innovation Park\, located in Essex\, within the established London-Stansted-Cambridge corridor. \nFor the first in our series of events held in collaboration with ARISE\, we’re taking the MedTech and Systems Special Interest Group (SIG) on the road. Born out of our longstanding partnership with Nottingham Trent University (NTU)\, this special interest group has met several times a year since it was first established in 2016\, and is a great example of how networks of this kind can strengthen connections between academia\, clinicians and industry. \nThis next event in the series explores how digital technologies are providing innovative solutions that are positively impacting mental health care and wellbeing more widely. We’ll hear talks from specialists working across this swiftly developing field\, covering topics ranging from AI and machine learning\, through to app-based interventions and interactive physical devices. \nThe event will be introduced by Professor Yvonne Barnett\, Deputy Vice Chancellor for Research and Innovation at Anglia Ruskin University and Medilink Midlands Board Member. Our presentations will be chaired by Professor Phil Breedon\, Professor of Smart Technologies at NTU and leader of the MedTech and Systems Special Interest Group since its launch. \nWe will hear presentations on the day from: \n\nProfessor Graham Ball\, Executive Director of the Medical Technologies Centre\, Anglia Ruskin University & Founder-CSO of Intelligent Omics\nDr Joseph C. Manning\, MBE\, Clinical Associate Professor for the NIHR and HEE based at the University of Nottingham\nDr Sarah Wright\, Global Account Director for Blueskeye\,\nDr Will Farr\, Chief Investigator within the NHS\, Tangiball\nEmilios Lemoniatis\, Director\, Frontline Buddy & Consultant Child and Adolescent Psychiatrist – Digital Ethics/Innovation\, Surrey and Borders Partnership NHS Foundation Trust\n\nOffered as a hybrid event\, we’d be delighted to welcome you in person on the day. We’ll be creating a dedicated networking space alongside the formal presentations\, as well as offering a tour of the facility. We encourage you to bring along your banners and any other take-home resources to facilitate connections between attendees and hopefully spark future collaborations. \nTo join us in person at Harlow Innovation Park\, click on the button below. \nSpeaker Profiles\n \nProfessor Graham Ball\, Executive Director of the Medical Technologies Centre\, Anglia Ruskin University & Founder-CSO of Intelligent Omics \nPresentation title: Digital Innovations for Mental Health – A Partnership Approach \nProf Graham Ball is the Executive Director of the Medical Technologies Research Centre at Anglia Ruskin University and founder-CSO of Intelligent Omics.  Prof Ball specializes in the application of innovative artificial intelligence and machine learning methods to the analysis of complex data in the biomolecular\, biomedical\, and pharmacological domains. \nProf Ball has led the development and validation of bioinformatics algorithms using Machine learning to mine molecular data for the last 20 years.  He has focused on applying these approaches to public data repositories leveraging actionable and translational features from the data.  He has published over 200 journal papers and 7 patents in this area.  After a PhD (UN-funded) modelling environmental systems\, in 2000 he shifted his focus to analysis of proteomic and genomic data; searching for proteins and genes associated with cancer.  His current research focuses on innovative computational methods that allow the identification of optimized biomarker panels\, molecular systems of disease and druggable biology. \n \nDr Joseph Manning MBE\, Clinical-Academic Children’s Nurse\, Nottingham University Hospitals Trust  \nPresentation title: The SAPhE Pathway Study – Using Digital Innovation to Enhance the Safety of Children and Young People Experiencing Mental Health Crisis in Acute Paediatric Care. \nJoseph is a Clinical-Academic Children’s Nurse with a strong national and international profile within the fields of nursing\, paediatric critical care\, and clinical academic capacity and capability development. He is the first registered children’s nurse in the UK to be awarded an HEE NIHR ICA Clinical Lectureship and is seen as a trailblazer in his field. \nHe has meaningful concurrent engagement in clinical practice and research\, holding frontline healthcare and senior leadership roles at Nottingham Children’s Hospital and an Associate Professorship (Research) / Deputy Director of the Centre for Children and Young People Health Research at the University of Nottingham. Joseph leads a methodologically diverse and clinically focused programme of research with a mission to improve the experiences\, outcomes and lives of children\, young people and their families that access acute care. Over the past decade he has received more than £5.4 million in competitive grant capture from national and international funders. His contribution and leadership to the nursing profession\, clinical academic careers\, and nursing research has been recognised by being a recipient of a Chief Nursing Officer for England Gold Lifetime Achievement Award in 2020 and by Her Majesty the Queen’s with a Member of the Order of the British Empire in 2021. \n \nDr Sarah Wright\, Global Account Director\, Blueskeye AI \nPresentation title: Using BlueSkeye AI Face Sensing Technology to Improve Quality of Life \nAfter graduating in Anthropology at Swansea University\, Sarah worked in market research in the Travel & Tourism sector before leading a European Funded programme to support Leadership Development in Industrial South Wales which in turn introduced Sarah to Telos Partners. At Telos Partners\, Sarah led and supported programmes of work with public\, private and voluntary sector organisations focussing on sustainable growth and development. Throughout this time Sarah continued with her academic interests completing an MSc in Social Research and her PhD. Sarah’s doctoral research focused on patient-centred care in outpatient settings. Sarah has 10 years’ experience working various roles in the health sector. Before joining BlueSkeye AI\, she previously led the roll out of Patients Know Best in the devolved nations and has contributed to the review and evaluation of the delivery of local mental health services and dermatology services in Wales. Sarah is also the Vice Chair for an all Wales skin charity\, Skin Care Cymru and set up the first Cross Party Group on Skin that raises the profile of skin health in Wales. Sarah is a trustee of the Telos Foundation\, an organisation that supports and encourages sustainability and growth amongst social enterprises in the UK. At BlueSkeye AI\, Sarah leads the commercial and research partnerships that use BlueSkeye AI technology. \n \nDr Will Farr\, Honorary Clinical Research Fellow at Brighton and Sussex Medical School\, NHS Clinical Entrepreneur \nPresentation title:“Tangiball”: Acceptability of a Smart Toy for the Clinical Detection of Sensori-Motor Dysfunction in Children with Possible Autism Aged 2-5 \nWill worked as a primary school teacher over 20 years and worked as a year 6\, 5\, and reception teacher. Whilst in this role he was a DH\, AHT\, SENCO\, and co-ordinator in IT\, PE\, KS2\, Humanities\, and Literacy. \nWill now works with collaborators across the University and Healthcare sectors in various Chief Investigator or Co-applicant roles\, to assess and improve the diagnostic pathways for children with possible autism\, digital innovation for diagnosis\, and use of AI for individualised therapy. \n \nEmilios Lemoniatis\, Director\, Frontline Buddy & Consultant Child and Adolescent Psychiatrist – Digital Ethics/Innovation\, Surrey and Borders Partnership NHS Foundation Trust \nPresentation title: Frontline Buddy: Peer Support for a Frontline Workforce with Organisational Data Insights \n“Working in a context of limited resources and challenging circumstances\, I have been drawn to the world of innovation and digital development as a way of enabling citizens to access high quality mental health services.  Working clinically with complex cases has enabled me to creatively transfer my skillset into working with systems and people to acknowledge difficulties in the way we work as well as find ways to adapt and change.  This has led me to my current position where I practice within a portfolio of teams with shared themes of adverse experience\, neurodiversity and complexity. \nI bring my experience of talking through difficulties as a psychiatrist to help people think creatively and dialogically. This helps people develop themselves and consider the materials they are working with to develop new insights and concepts.  Having been on the NHS England Clinical Entrepreneur programme since 2019 both as a entrepreneur and as a mentor to start-ups in mental health\, I am a go-to person to guide new developments in mental health as well as understanding and living the entrepreneurial spirit of the work involved.  This has also helped me further develop my network that I have been developing nationally and internationally of people\, products and companies in this field for over 15 years.” \n 
URL:https://staging.medilinkmidlands.com/event/digital-technologies-for-positive-mental-health-and-wellbeing/
LOCATION:Harlow Innovation Park\, CM17 9LX
CATEGORIES:Featured,Medilink Midlands Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/09/Mental-Health.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221011T100000
DTEND;TZID=Europe/London:20221011T110000
DTSTAMP:20260408T154022
CREATED:20200616T075103Z
LAST-MODIFIED:20221005T053244Z
UID:19738-1665482400-1665486000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Making Sense of Intellectual Property for Medtech Start-Ups
DESCRIPTION:This talk is aimed at inventors and technologists\, leaders and entrepreneurs at medtech start-ups and early stage companies. \nIntellectual property is the most important asset of most tech start-ups.  Ensuring that your IP is protected in an appropriate way is a significant consideration when seeking funding to grow and underpins the future success of your company. \nThis talk outlines things to consider when you are starting out to put your IP strategy on a good path to protect your innovation\, get ready for investment and avoid some common mistakes. \nJoin Medilink\, Dr Daniel Hudson\, UK and European Patent Attorney\, Partner at Potter Clarkson and Clark Crawford\, Innovation & Commercial Services lead\, West Midlands Academic Health Science Network (WMAHSN) at this webinar to understand and ‘make sense’ of intellectual property in the medtech space. \nDURATION: 1 hour \nTO SECURE YOUR FREE PLACE CLICK HERE\nSpeaker: \n \nDr Daniel Hudson\, UK and European Patent Attorney\, Partner at Potter Clarkson\nDaniel is a partner in the electronics and computing patent group at Potter Clarkson\, an award-winning\, top-tier firm of European patent and trade mark attorneys and IP solicitors. He works with innovative organisations to recognise and protection inventions. Dan drafts and prosecutes UK and European patent applications in the digital heath space\, and works with patent attorneys around the world to manage the international prosecution of families of patent applications. He particularly enjoys addressing the challenges involved with prosecuting related families of patent applications to obtain comprehensive protection for his clients’ inventions in view of their commercial objectives.
URL:https://staging.medilinkmidlands.com/event/ip-making-sense-of-intellectual-property-for-medtech-start-ups/
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Medilink Midlands":MAILTO:zoeh@medilinkwm.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221005T173000
DTEND;TZID=Europe/London:20221005T203000
DTSTAMP:20260408T154022
CREATED:20220922T073832Z
LAST-MODIFIED:20220922T151032Z
UID:20510-1664991000-1665001800@staging.medilinkmidlands.com
SUMMARY:City of Mentor Midlands Meet Up
DESCRIPTION:Medilink Midlands and the Greater Birmingham Transatlantic Chamber of Commerce invite you to an informal evening to meet with colleagues from the City of Mentor. \nWe are delighted to be welcoming a team of representatives from our longstanding partners at the City of Mentor\, Ohio to the UK on their latest trade mission\, including: \n\nKen Filipiak\, City Manager/CEO\, City of Mentor\nKevin Malecek\, Director of Economic Development and International Trade\, City of Mentor\nKim Holizna from the Ohio Aerospace Institute (TBC)\n\nThis informal networking event\, offers you the chance to scope out potential opportunities for entering the lucrative US market. The City of Mentor is a powerhouse of innovation\, being home to more than 300 manufacturers with particular strengths in advanced manufacturing\, aerospace\, polymer\, and biomedical industry clusters. This setting will provide a forum to discuss the prospects for investment in the City of Mentor\, as well as establishing connections between UK healthcare\, aerospace\, and precision manufacturing businesses and appropriate partners and organisations in the US. \nUvamed\, a Medilink member company\, were introduced to our City of Mentor partners during their first visit in 2018 and have been working with them ever since. Keith Fawdington\, Uvamed’s Director\, writes: \n“Uvamed has long held ambitions to expand into the US. Our products fulfil a real need in the American healthcare market and Medilink Midlands\, working in collaboration with the City of Mentor and Uvamed\, have helped us towards that ambition. Since attending the first Medilink Midlands trade mission in October 2018\, Uvamed has worked with Medilink and the City of Mentor to establish US offices and make in-roads into America.” \nFor your chance to open the door to similar success\, join us at the Edgbaston Park Hotel\, Birmingham on Wednesday 5th October from 5.30pm . \nEmail zoeh@medilinkmidlands.com to confirm your place. \nFurther information on the City of Mentor can be found City of Mentor
URL:https://staging.medilinkmidlands.com/event/an-informal-evening-with-the-city-of-mentor/
LOCATION:Edgbaston Park Hotel and Conference Centre\, 53 Edgbaston Park Road\, Birmingham\, B15 2RS
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Medilink Midlands":MAILTO:zoeh@medilinkwm.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220616T093000
DTEND;TZID=Europe/London:20220616T130000
DTSTAMP:20260408T154022
CREATED:20220525T084659Z
LAST-MODIFIED:20221222T100456Z
UID:19191-1655371800-1655384400@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Food Supplements Special Interest Group (SIG)
DESCRIPTION:*Please note that this event is in-person attendance only* \nThe next Food Supplements SIG in partnership with JensonR+ is taking place at Charnwood Campus and will cover the following: \n– Marketing Oversights – Over the Counter Food Supplements\n– Cannabidiol (CBD)\n– Probiotics\n– Impact of Brexit – Updates since Oct 2021 \nFull programme and speaker biographies to follow.\n\nTo book your free place\, please complete the online booking form below.  Please note the booking system is not automated and a member of the events team will confirm your place to you soon. \n		\n					\n						\n					\n			\n						\n				\n									\n					\n						\n									BOOK NOW\n					\n					\n				\n								\n				\n					\n		\n					\n		\n				\n		\n  \nThis free-to-attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £445\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to companies in the Derby/Derbyshire/Nottingham/Nottinghamshire area and is open to all.
URL:https://staging.medilinkmidlands.com/event/in-person-event-food-supplements-special-interest-group-sig/
LOCATION:Charnwood Campus\, Bakewell Road\, Loughborough\, LE11 5RB
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/05/pills-g26dc0ff7e_1920.jpg
ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com
END:VEVENT
END:VCALENDAR